Today we will be presenting poster FPN 550P:
"Retrospective analysis of molecular resistance biomarkers to trastuzumab deruxtecan (T-DXd) in metastatic breast cancer (mBC)"
📍 : Poster Area, ESMO 2025
🕛 : Today at 12:00 PM
#ESMO2025 #BreastCancer
Today we will be presenting poster FPN 550P:
"Retrospective analysis of molecular resistance biomarkers to trastuzumab deruxtecan (T-DXd) in metastatic breast cancer (mBC)"
📍 : Poster Area, ESMO 2025
🕛 : Today at 12:00 PM
#ESMO2025 #BreastCancer
Grateful for the chance to learn, connect, and get inspired by brilliant minds in cancer research.
Thanks to @cancercoreeurope.bsky.social & @gustaveroussy.fr for the opportunity!
#CancerResearch #Oncology
Grateful for the chance to learn, connect, and get inspired by brilliant minds in cancer research.
Thanks to @cancercoreeurope.bsky.social & @gustaveroussy.fr for the opportunity!
#CancerResearch #Oncology
Our review on radioligand therapy in mBC is now published in Cancer Treatment Reviews.
Huge thanks to the whole team, especially Carmen Criscitiello for her mentorship.
🔗 doi.org/10.1016/j.ct...
#breastcancer #RLT #precisionmedicine #theranostics #nuclearmedicine #oncology
Our review on radioligand therapy in mBC is now published in Cancer Treatment Reviews.
Huge thanks to the whole team, especially Carmen Criscitiello for her mentorship.
🔗 doi.org/10.1016/j.ct...
#breastcancer #RLT #precisionmedicine #theranostics #nuclearmedicine #oncology